Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Thyroid Neoplasms 1Sarcoma 1Recurrence 1Head and Neck Neoplasms 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Magnetic Resonance Spectroscopy 10trametinib 7Nivolumab 7selpercatinib 6pembrolizumab 6dabrafenib 6Iodine-131 6Specimen Handling 5Biopsy 5lenvatinib 4Vemurafenib 4Iodine-124 4durvalumab 3cabozantinib 3binimetinib 3Ipilimumab 3Immunoglobulin G 3Fluorodeoxyglucose F18 3Disulfides 3Cyclophosphamide 3Cetuximab 3vandetanib 2ulixertinib 2omipalisib 2larotrectinib 2defactinib 2copanlisib 2cemiplimab 2anlotinib 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × perflutren × 1 year × Clear all
NCT04136912 2025-10-06

3-D Super Resolution Ultrasound Microvascular Imaging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
27 enrolled 12 charts
BreastHead & Neck

Breast Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡